Fund shareholders of Viking Therapeutics Inc
ISIN US92686J1060 · United States · LEI 529900IVC72YPFA25M37
- Fund shareholders
- 252
- Of which ETFs
- 65 187 other funds
- Value held
- 885.3M $ 703.8K € · 14.8M SEK
- Share of capital
- 23.4 % of 116.7M shares on Jul 15, 2026
252 funds hold this company. This table lists the 251 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Goldman Sachs MarketBeta(R) Russell 1000 Value Equity ETF Goldman Sachs ETF Trust | 1,288 | 43.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| BlackRock Advantage Large Cap Value V.I. Fund BlackRock Variable Series Funds, Inc. | 1,282 | 41.7K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth Index Fund SCHWAB CAPITAL TRUST | 1,201 | 37.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Large Cap Growth Managed Volatility Portfolio EQ Advisors Trust | 1,147 | 37.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 1,129 | 36.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 1,044 | 32.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 1,000 | 31.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 928 | 28.9K $ | 0.79 % | 0.00 % | as of Apr 30, 2026 ↗ |
| BNY Mellon Mid Cap Multi-Strategy Fund BNY MELLON FUNDS TRUST | 810 | 27.4K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| The Institutional U.S. Equity Portfolio HC Capital Trust | 807 | 26.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 800 | 26K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Value ETF Columbia ETF Trust I | 791 | 24.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Large Cap Growth Index Portfolio EQ Advisors Trust | 769 | 25K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 760 | 24.7K $ | 0.20 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 707 | 23K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 700 | 22.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Large Cap Growth Index Fund Fidelity Salem Street Trust | 696 | 21.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 658 | 21.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 636 | 20.7K $ | 0.91 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 633 | 20.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 631 | 21.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 593 | 18.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 545 | 18.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| AMT Diversified Equity Fund ADVISER MANAGED TRUST | 518 | 16.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 513 | 17.4K $ | 0.19 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 461 | 15K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 360 | 11.2K $ | 0.15 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 336 | 11.4K $ | 0.19 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PD Large-Cap Growth Index Portfolio PACIFIC SELECT FUND | 315 | 10.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco QQQ Hedged Advantage ETF Invesco Actively Managed Exchange-Traded Fund Trust | 312 | 9.7K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 255 | 8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 246 | 8K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 241 | 7.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VOYA RUSSELLTM MID CAP GROWTH INDEX PORTFOLIO Voya VARIABLE PORTFOLIOS INC | 213 | 6.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL Russell 1000 Growth Index Fund Allianz Variable Insurance Products Trust | 176 | 5.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LargeCap Growth Fund I Principal Funds, Inc | 174 | 5.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| JPMorgan Fundamental Data Science Mid Core ETF J.P. Morgan Exchange-Traded Fund Trust | 170 | 5.5K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Sector Rotation Fund Meeder Funds | 155 | 5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Goldman Sachs ETF Trust | 137 | 4.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 132 | 4.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 65 | 2.2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 48 | 1.6K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 42 | 1.4K $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| LargeCap Growth Account I Principal Variable Contract Funds, Inc | 31 | 1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 26 | 846 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Enhanced Large Cap Core Active ETF BlackRock ETF Trust | 17 | 530.1 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 4 | 135.4 $ | 0.00 % | as of Feb 28, 2026 ↗ | |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 324.2K € | 0.87 % | as of Dec 31, 2025 ↗ | ||
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 299.4K € | 0.36 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 58.7K € | 1.60 % | as of Dec 31, 2025 ↗ | ||
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 21.4K € | 0.64 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Roundhill GLP-1 & Weight Loss ETF Roundhill ETF Trust | 5.29 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 2.47 % | as of Feb 28, 2026 ↗ |
| Wasatch Ultra Growth Fund WASATCH FUNDS TRUST | 2.43 % | as of Mar 31, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 2.21 % | as of Mar 31, 2026 ↗ |
| Nomura Healthcare Fund Delaware Group Equity Funds IV | 1.62 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 1.60 % | as of Dec 31, 2025 ↗ |
| Formidable ETF ETF Opportunities Trust | 1.45 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.15 % | as of Sep 30, 2025 ↗ |
| WesMark Small Company Fund WesMark Funds | 1.07 % | as of Mar 31, 2026 ↗ |
| Lannebo Hälsa och Ny Teknik Lannebo Kapitalförvaltning AB | 1.04 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 245 | +1 | 27,250,114 | +3.7 % |
| 2026Q1 | 244 | 0 | 26,274,138 | -3.2 % |
| 2025Q4 | 244 | -25 | 27,154,704 | -15.7 % |
| 2025Q3 | 269 | +12 | 32,199,420 | -7.3 % |
| 2025Q2 | 257 | -35 | 34,752,020 | -8.5 % |
| 2025Q1 | 292 | -27 | 37,988,032 | -1.0 % |
| 2024Q4 | 319 | -7 | 38,377,502 | -6.0 % |
| 2024Q3 | 326 | 0 | 40,813,744 | +12.3 % |
| 2024Q2 | 326 | +133 | 36,341,399 | -0.8 % |
| 2024Q1 | 193 | +11 | 36,650,059 | +6.7 % |
| 2023Q4 | 182 | 34,346,280 |
Institutional managers
399 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 6,880,290 | 223.9M $ | as of Mar 31, 2026 |
| FMR LLC | 6,024,753 | 196M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 4,432,142 | 144.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,395,557 | 143M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 3,013,928 | 98.1M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,082,067 | 67.8M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 2,078,577 | 67.6M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 2,075,403 | 113.5M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 1,678,745 | 54.6M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,676,713 | 54.6M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,347,472 | 43.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,262,221 | 41.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 960,570 | 31.3M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 914,147 | 29.7M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 748,949 | 24.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 736,465 | 24M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 705,809 | 23M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 696,301 | 22.7M $ | as of Mar 31, 2026 |
| BlackBarn Capital Partners LP | 621,450 | 20.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 573,276 | 18.7M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 542,516 | 17.7M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 540,499 | 17.6M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 525,484 | 17.1M $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 525,181 | 17.1M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 516,108 | 16.8M $ | as of Mar 31, 2026 |
Declared shareholders of Viking Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.08 % | 5,877,263 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Viking Therapeutics Inc". https://titelia.com/en/stocks/viking-therapeutics-inc-US92686J1060